Tanja Obradovic: AACR issues Cancer Progress Report 2024 with a focus on young adults and children

Tanja Obradovic shared the following on LinkedIn:

“AACR just issued Cancer Progress Report 2024, which provides status assessment for the overall population but also has a special focus on young adults, adolescents, and children.

A very informative read, as it summarizes approved novel therapies, screening, and IT tools getting clearance so far in 2024. Outstanding work by AACR contributors who put all into perspective while also highlighting truly urgent needs for diversity and critical venues for new drug development.”

Source: Tanja Obradovic/LinkedIn

More posts featuring Tanja Obradovic on oncodaily.com

Tanja Obradovic is the Vice President of Oncology Scientific Affairs at ICON PLCh. She has over 20 years of clinical research experience and has led major pharmaceutical companies for 13 years. Her research focuses on small molecules, antibodies, cell and gene therapy, and major immunotherapy of PD1 inhibitors.